Get started
Author

Nuramalina H Mumin

Observed names: Nuramalina H. Mumin, Nuramalina Mumin
ORCID: 0000-0002-0588-9940
Observed ORCID: 0000-0002-0588-9940
OpenAlex ID: A5073883476
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
2019 · Nuramalina H. Mumin, Neele Drobnitzky, et al. · BMC Cancer · 41
PDF
Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
2021 · Aziemah Azizi, Nuramalina H Mumin, et al. · F1000Research · 38
PDF
Conducting multiple mini-interviews in the midst of COVID-19 pandemic
2021 · Kenneth Yy Kok, Lie Chen, et al. · Medical Education Online · 23
Green Synthesis of Silver Nanoparticles Using Plant Extracts: Recent Advances in Mechanisms, Parameters, and Characterization Methods
2025 · Nurul Ashifah Shafie, Sheba R David, et al. · Current Drug Therapy · 10
Formulation and development of Commiphora myrrha based polyherbal nanoemulsion mouthwash and assessment of its anti-oxidant and cytotoxicity activity
2024 · Norafiqah Yusof, Sheba R David, et al. · Journal of Applied Pharmaceutical Research · 4
PDF
Herbal mouthwashes for oral mucositis in cancer therapy: A systematic review
2025 · Norafiqah Yusof, Nuramalina H Mumin, et al. · Journal of Oral Health and Oral Epidemiology · 1
PDF
Formulation of Curcumin-based Polyherbal Nanoemulsion Mouthwash and Assessment of its Antioxidant and in-vitro Cytotoxic Properties
2024 · Norafiqah Yusof, Nurhafizah Hamid, et al. · Current Trends in Biotechnology and Pharmacy · 1
Green Synthesis of Silver Nanoparticles Using Aqueous Plant Extracts and their Anticancer Activity against Colorectal Cancer: A Systematic Review
2026 · Nurul Ashifah Shafie, Nuramalina H Mumin, et al. · The Natural Products Journal
Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam
2025 · Siti Nur Idayu Matusin, Nuramalina Mumin, et al. · PLoS ONE
PDF
Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
2021 · Aziemah Azizi, Nuramalina H Mumin, et al. · F1000Research
PDF
Abstract C114: The role of LKB1 and TP53 mutation status in determining sensitivity of non-small cell lung cancer cells to the metabolic inhibitors; metformin, phenformin and 2-DG
2015 · Fiona F. Cahill, Sivan Bokobza, et al. · Molecular Cancer Therapeutics
Abstract B88: Mechanisms of resistance to the Hsp90 inhibitor ganetespib in triple negative breast cancer
2015 · Nuramalina H. Mumin, Sivan Bokobza, et al. · Molecular Cancer Therapeutics
Works count: 12
Citation count: 118
H-index: 4
I10-index: 4
Year
Topic
Type